Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pitchai Balakumar

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Pharmacological Research|January 31, 2012
Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?Pitchai Balakumar, Supriya Kadian, Nanjaian Mahadevan
Pharmacology|May 15, 2007
PPAR ligands: are they potential agents for cardiovascular disorders?Pitchai Balakumar, Madhankumar Rose, Manjeet Singh
Molecular and Cellular Biochemistry|May 6, 2009
Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?Pitchai Balakumar, Jayarami Reddy, Manjeet Singh
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 18, 2013
Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heartLalita Babbar, Nanjaian Mahadevan, Pitchai Balakumar
Cardiovascular Toxicology|August 10, 2010
The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the ratJagdeep Kaur, Krishna Reddy, Pitchai Balakumar
European Journal of Pharmacology|October 23, 2012
Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathySupriya Kadian, Nanjaian Mahadevan, Pitchai Balakumar
Molecular and Cellular Biochemistry|November 15, 2012
Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalitiesSonam Kathuria, Nanjaian Mahadevan, Pitchai Balakumar
Pharmacology|June 16, 2007
Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in ratsMadhankumar Rose, Pitchai Balakumar, Manjeet Singh
Pharmacological Research|September 28, 2015
Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminatedPitchai Balakumar, Muthu Kavitha, Suresh Nanditha
Biological Trace Element Research|November 28, 2009
The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunctionSanjali Verma, Krishna Reddy, Pitchai Balakumar
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Pharmacological Research|January 31, 2012
Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?Pitchai Balakumar, Supriya Kadian, Nanjaian Mahadevan
Pharmacology|May 15, 2007
PPAR ligands: are they potential agents for cardiovascular disorders?Pitchai Balakumar, Madhankumar Rose, Manjeet Singh
Molecular and Cellular Biochemistry|May 6, 2009
Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?Pitchai Balakumar, Jayarami Reddy, Manjeet Singh
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 18, 2013
Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heartLalita Babbar, Nanjaian Mahadevan, Pitchai Balakumar
Cardiovascular Toxicology|August 10, 2010
The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the ratJagdeep Kaur, Krishna Reddy, Pitchai Balakumar
European Journal of Pharmacology|October 23, 2012
Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathySupriya Kadian, Nanjaian Mahadevan, Pitchai Balakumar
Molecular and Cellular Biochemistry|November 15, 2012
Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalitiesSonam Kathuria, Nanjaian Mahadevan, Pitchai Balakumar
Pharmacology|June 16, 2007
Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in ratsMadhankumar Rose, Pitchai Balakumar, Manjeet Singh
Pharmacological Research|September 28, 2015
Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminatedPitchai Balakumar, Muthu Kavitha, Suresh Nanditha
Biological Trace Element Research|November 28, 2009
The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunctionSanjali Verma, Krishna Reddy, Pitchai Balakumar
Pageof 10